| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 0.0 | 0.1 | 0.2 |
| Total income | 1.6 | 2.7 | 0.2 |
| Net profit | 0.0 | 0.1 | 0.0 |
| Operating margin | 0.0% | 7.4% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, BSE: 543499. Figures extracted from the filing.
Achyut Healthcare Ltd: key numbers
- Share price
- ₹6.00
- Market cap
- ₹144.8 Cr
- Revenue (annual)
- ₹11.59 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- 445.4×Sector 49.8×
- Promoter holding
- 47.40%+0.00% QoQ
- FII holding
- 5.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Achyut Healthcare Ltd
All →Achyut Healthcare Management Change
Achyut Healthcare re-appointed Jigen J. Modi as Executive Director and Sonu L. Jain and Rutvik S. Thakkar as Independent Directors for 60-month terms.
Achyut Healthcare Annual Report
Achyut Healthcare Limited has submitted its 31st Annual Report for the financial year 2025-2026. The Annual General Meeting is scheduled for 29th September, 2026.
Achyut Healthcare Board Meeting Outcome
Achyut Healthcare's board approved the AGM notice for September 29, 2026, and re-appointed the Managing Director and two Independent Directors for five-year terms.
Achyut Healthcare Annual General Meeting
Achyut Healthcare announces the re-appointment of its Managing Director and two Independent Directors, and schedules its 31st Annual General Meeting for September 29, 2026.
Achyut Healthcare Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
Achyut Healthcare Ltd reported revenue from operations of ₹3.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
Achyut Healthcare Board Meeting Date
Achyut Healthcare Limited scheduled a board meeting on August 13, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.